Hepatitis C Virus
Scientists at Baylor University describe research in hepatitis C virus
Published in Hepatitis Weekly, January 14th, 2008
"This work is a 1-yr interim analysis of a prospective, randomized, multicenter trial evaluating the effect of corticosteroid-free immunosuppression on hepatitis C virus-positive (HCV+) liver transplant recipients following liver transplantation (LT). Patients received tacrolimus and corticosteroids (Arm 1; n = 80); tacrolimus, corticosteroids, and mycophenolate mofetil (MMF) (Arm 2; In = 79); or daclizumab induction, tacrolimus, and MMF (Arm 3; n = 153)," investigators in the United States report.
"At 1 yr, 64.1%, 63.4%, and 69.4% of patients achieved the composite primary endpoint of freedom from rejection, freedom from HCV recurrence, and freedom from treatment...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-01-14)
More Articles from Hepatitis Weekly
- Cancer Vaccines
Studies from University of California in the area of cancer vaccines published - Cholestasis
Research on cholestasis discussed by scientists at Columbia University - Cirrhosis
New findings from B.H. Ferraz and co-authors describe advances in cirrhosis - Fatty Liver
Research data from G. Bedogni and colleagues update understanding of fatty liver - Hepatitis
Data from Z. Liu et al provide new insights into hepatitis - Hepatitis A Virus
Researchers from Merck & Company, Inc. report recent findings in hepatitis A virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
